
![BD HorizonTM BV605 Mouse Anti-Mouse H-2K[b]/SIINFEKL](https://biomall.ai/api/proxy-image?url=https%3A%2F%2Fwww.bdbiosciences.com%2Fcontent%2Fdam%2Fbdb%2Fproduct_assets%2Fproduct_image%2Fsingcolorpureantibody%2Fbv605%2Fimage_0%2F570014_570095-2.png%3Fimwidth%3D320)
570095 · 25 ug
BDB Bioscience · Cat: 570095
Reach 3+ verified distributors
Manufacturer product page
bdbiosciences.com/en-us/products/reagents/flow-cytometry-rea...
Description
Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV605 Mouse IgG1, kappa Isotype Control Cat. No. 562652; dashed line histograms or with BD Horizon BV605 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570014/570095; solid line histograms at 0.5 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing H-2K b /SIINFEKL expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV605 Mouse IgG1, kappa Isotype Control Cat. No. 562652; Left Plot or BD Horizon BV605 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570014/570095; Right Plot at 0.5 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV605 Mouse IgG1, kappa Isotype Control Cat. No. 562652; dashed line histograms or with BD Horizon BV605 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570014/570095; solid line histograms at 0.5 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing H-2K b /SIINFEKL expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV605 Mouse IgG1, kappa Isotype Control Cat. No. 562652; Left Plot or BD Horizon BV605 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570014/570095; Right Plot at 0.5 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Show More Flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with or without prior SIINFEKL peptide treatment. Mouse splenocytes were either not pulsed Left Plot or were pulsed Right Plot with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV605 Mouse IgG1, kappa Isotype Control Cat. No. 562652; dashed line histograms or with BD Horizon BV605 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570014/570095; solid line histograms at 0.5 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The fluorescence histograms showing H-2K b /SIINFEKL expression or Ig Isotype control staining were derived from gated events with the forward and side light-scatter characteristics of viable DAPI-negative splenic leukocytes. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific. Multiparameter flow cytometric analysis of H-2K b /SIINFEKL expression on viable C57BL/6 Mouse splenic leukocytes with prior SIINFEKL peptide treatment. Mouse splenocytes were pulsed with SIINFEKL peptide for 2 hours and were then preincubated with Purified Rat Anti-Mouse CD16/CD32 antibody Mouse BD Fc Block Cat. No. 553142 . The cells were stained with either BD Horizon BV605 Mouse IgG1, kappa Isotype Control Cat. No. 562652; Left Plot or BD Horizon BV605 Mouse Anti-Mouse H-2K b /SIINFEKL antibody Cat. No. 570014/570095; Right Plot at 0.5 mug/test. DAPI Solution Cat. No. 564907 was added to cells right before analysis. The bivariate pseudocolor density plot showing the correlated expression of H-2K b /SIINFEKL or Ig Isotype control staining versus side-light scatter SSC-A signals was derived from gated events with the forward and side-light scatter characteristics of viable DAPI-negative splenic leukocyte populations. Flow cytometry and data analysis were performed using a BD LSRFortessa X-20 Cell Analyzer System and FlowJo Software. Data shown on this Technical Data Sheet are not lot specific.







